Accustem Sciences Inc.
ACUT · OTCMCIK 1850767fmd_1WKM580X1JBFGV8NFVP0JY7M10Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2021 to Jun 30, 2026, 22 periods
| Line item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Research and development | 0 | 0 | 0 | 0 | 0 |
| Total operating expenses | 1 | 4 | 2 | 2 | 2 |
| Operating income | (1) | (4) | (2) | (2) | (2) |
| Income before taxes | (1) | (4) | (2) | (2) | (2) |
| Net income | (1) | (4) | (2) | (2) | (2) |
| Net income to common shareholders | (1) | (4) | (2) | (2) | (2) |